Purpose: To correlate spectral domain optical coherence tomography (SD-OCT) and photographic imaging before and after spontaneous regression of primary vitreoretinal lymphoma (PVRL) lesions. Procedures: We report the case of a 60-year-old female. Results: The patient presented with bilateral creamy deposits under the retina and retinal pigment epithelium (RPE), and lesions were visible along Bruch's membrane with SD-OCT and suspicious for PVRL. Systemic workup revealed nonspecific areas of enhancement on neuroimaging. The patient was largely asymptomatic and the decision was made to observe her. Three months later, a new lesion pattern had developed. The color fundus photographs and SD-OCT demonstrated spontaneous regression of the largest sub-RPE lesion, leaving areas of RPE atrophy, while a new larger sub-RPE lesion had formed in the other eye. Vitreous biopsy showed lymphocytes and no malignant cells, while sub-RPE biopsy of the newly formed lesion revealed highly atypical cells positive for CD19 and CD20. Conclusions: Multimodal imaging documents that PVRL lesion regression and early RPE changes can develop within a 3-month period. Immune control is an important factor in lesion regression in the eye.
Introduction
Primary vitreoretinal lymphoma (PVRL) is a rare subset of primary central nervous system (CNS) lymphoma [1, 2] . While malignancies rarely spontaneously regress, subretinal PVRL lesions have been previously reported to migrate or regress without treatment [3] .
However, there is little documentation of this observation in the literature with modern imaging techniques. Here, we correlate the photographic and spectral domain optical coherence tomography (SD-OCT) findings in a case of spontaneous lesion regression in a treatment-naïve patient with PVRL.
Case Report
The patient is a 60-year old female with a past medical history significant for hypothyroidism and type 2 diabetes. Her cancer family history was positive for lymphoma and prostate cancer in her father. She had a 1-year history of intermittent scotomata and decreased vision in OU and a 3-week history of photophobia and metamorphopsia in OU resistant to topical prednisolone that she received from an outside clinic. The review of systems was otherwise unremarkable.
On presentation to our department, her visual acuity was 20/30 in the OD, 20/20 in the OS with quiet anterior segments and vitreous OU and multiple subretinal/subretinal pigment epithelium (RPE) creamy deposits in OU ( fig. 1 a, c) . Fundus autofluorescence pictures showed a mixed pattern of increased and decreased autofluorescence ( fig. 2 a) , while fluorescein angiography demonstrated early blockage in the subretinal material followed by late mild hyperfluorescence ( fig. 2 b, c) . The SD-OCT showed accumulation of predominantly sub-RPE material along Bruch's membrane ( fig. 1 e) . Brain MRI ( fig. 2 d) showed multiple nonspecific areas of enhancement within the brain parenchyma. These areas were suspicious for CNS lymphoma involvement given her ocular findings, but were not considered significant enough to biopsy. Chest CT was positive for nonspecific indeterminate nodules, while MRI of the orbits, CT of the abdomen and pelvis, as well as PET scan were unremarkable. Bone marrow biopsy and lumbar puncture were negative for any abnormal cell populations.
Laboratory testing was within normal limits including complete blood count, ACE, lysozyme, ANA, ESR, pANCA, cANCA, RPR, quantiferon TB-Gold, Lyme IgG/IgM, serum protein electrophoresis, and LDH. Due to excellent visual acuity and very limited disease burden, the decision was made to closely observe the patient and biopsy with any worsening. The neuro-oncologist also recommended observation until a tissue diagnosis was obtained.
At the 3-month follow-up, the patient's vision decreased to 20/50 in the OD and 20/25 in the OS. The previously documented lesions had regressed in OU, while new sub-RPE lesions appeared in other areas in OU ( fig. 1 b, d ). SD-OCT through the largest prior lesion showed regression of the subretinal and sub-RPE material, improved visualization of the choriocapillaris, and mild atrophy of the RPE ( fig. 1 f) . Vitrectomy and sub-RPE biopsy of the largest lesion were performed in the OD. Cytology of the vitreous showed lymphocytes and an eosinophil. Flow cytometry and cytology of the sub-RPE biopsy were negative for CD8+ T cells or NK cells and positive for a dominant population of highly atypical B cells co-expressing CD19 and CD20, consistent with B-cell lymphoproliferative disorder. Thus, systemic treatment with rituximab and methotrexate was initiated by neuro-oncology given the mild CNS findings on MRI. The patient's lesions regressed well with systemic treatment.
Discussion
Spontaneous resolution of the primary neoplastic lesion is an unusual phenomenon in any malignancy, but this observation has been made for PVRL and other non-Hodgkin's lymphoma types [3, 4] . The color fundus photographs and SD-OCT images of this report provide documentation that PVRL lesions can regress without treatment, leaving an area of RPE atrophy. The exact mechanism or clinical significance of these lesion changes is hypothesized to be due to tumor control by the host immune system, primarily by CD8+ T cells [3, 4] as well as NK cells [5] . In this case, the patient's vitreous biopsy showed a predominant population of non-neoplastic lymphocytes, providing support of immune surveillance, while the sub-RPE biopsy of the newly formed lesion did not. Further elucidation of these mechanisms of immunologic tumor control and migration is valuable since it could open new therapeutic approaches against the malignant process.
